10.1084/jem.192.8.f21
Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Bibliography

Roy, S., & Nicholson, D. W. (2000). Cross-Talk in Cell Death Signaling. The Journal of Experimental Medicine, 192(8), F21–F26.

Authors 2
  1. Sophie Roy (first)
  2. Donald W. Nicholson (additional)
References 15 Referenced 206
  1. 10.1146/annurev.cellbio.15.1.269 / Annu. Rev. Cell Dev. Biol / Biochemical pathways of caspase activation during apoptosis by Budihardjo (1999)
  2. 10.1016/S0092-8674(00)00003-9 / Cell / Apoptotic pathwayspaper wraps stone blunts scissors by Green (2000)
  3. 10.1126/science.288.5475.2354 / Science / Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations by Siegel (2000)
  4. 10.1126/science.288.5475.2351 / Science / A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling by Chan (2000)
  5. 10.1093/emboj/17.6.1675 / EMBO (Eur. Mol. Biol. Organ.) J / Two CD95 (APO-1/Fas) signaling pathways by Scaffidi (1998)
  6. 10.1074/jbc.274.32.22532 / J. Biol. Chem / Differential modulation of apoptosis sensitivity in CD95 type I and type II cells by Scaffidi (1999)
  7. 10.1016/S0092-8674(00)81589-5 / Cell / Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors by Luo (1998)
  8. 10.1016/S0092-8674(00)81590-1 / Cell / Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis by Li (1998)
  9. 10.1038/nm0196-80 / Nat. Med / Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice by Lacronique (1996)
  10. 10.1084/jem.183.3.1031 / J. Exp. Med / A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection by Rodriguez (1996)
  11. 10.1038/23730 / Nature / Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis by Yin (1999)
  12. 10.1073/pnas.96.26.14871 / Proc. Natl. Acad. Sci. USA / Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L) by Huang (1999)
  13. 10.1038/sj.cdd.4400569 / Cell Death Differ / Differences between CD95 type I and II cells detected with the CD95 ligand by Schmitz (1999)
  14. 10.1038/sj.cdd.4400683 / Cell Death Differ. / Bcl-2 does not inhibit cell death induced by the physiological Fas ligandimplications for the existence of type I and type II cells by Huang (2000)
  15. 10.1084/jem.192.5.647 / J. Exp. Med. / Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinaseregulators of distinct cell death and survival pathways in granulocytes by Villunger (2000)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 12:48 p.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 6:43 a.m.)
Indexed 1 week ago (Aug. 20, 2025, 8:36 a.m.)
Issued 24 years, 10 months ago (Oct. 16, 2000)
Published 24 years, 10 months ago (Oct. 16, 2000)
Published Online 24 years, 10 months ago (Oct. 16, 2000)
Published Print 24 years, 10 months ago (Oct. 16, 2000)
Funders 0

None

@article{Roy_2000, title={Cross-Talk in Cell Death Signaling}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.8.f21}, DOI={10.1084/jem.192.8.f21}, number={8}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Roy, Sophie and Nicholson, Donald W.}, year={2000}, month=oct, pages={F21–F26} }